The Long-term Outcomes and Risk Factors of Complications After Fontan Surgery: From the Korean Fontan Registry (KFR)
- Author:
Sang-Yun LEE
1
;
Soo-Jin KIM
;
Chang-Ha LEE
;
Chun Soo PARK
;
Eun Seok CHOI
;
Hoon KO
;
Hyo Soon AN
;
I Seok KANG
;
Ja Kyoung YOON
;
Jae Suk BAEK
;
Jae Young LEE
;
Jinyoung SONG
;
Joowon LEE
;
June HUH
;
Kyung-Jin AHN
;
Se Yong JUNG
;
Seul Gi CHA
;
Yeo Hyang KIM
;
Youngseok LEE
;
Sanghoon CHO
Author Information
- Publication Type:Original Research
- From:Korean Circulation Journal 2024;54(10):653-668
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background and Objectives:This study aimed to analyze the outcomes of Fontan surgery in the Republic of Korea, as there were only a few studies from Asian countries.
Methods:The medical records of 1,732 patients who underwent Fontan surgery in 10 cardiac centers were reviewed.
Results:Among them, 1,040 (58.8%) were men. The mean age at Fontan surgery was 4.3±4.2 years, and 395 (22.8%) patients presented with heterotaxy syndrome. According to the types of Fontan surgery, 157 patients underwent atriopulmonary (AP) type; 303, lateral tunnel (LT) type; and 1,266, extracardiac conduit (ECC) type. The overall survival rates were 91.7%, 87.1%, and 74.4% at 10, 20, and 30 years, respectively. The risk factors of early mortality were male, heterotaxy syndrome, AP-type Fontan surgery, high mean pulmonary artery pressure (mPAP) in pre-Fontan cardiac catheterization, and early Fontan surgery year. The risk factors of late mortality were heterotaxy syndrome, genetic disorder, significant atrioventricular valve regurgitation (AVVR) before Fontan surgery, high mPAP in pre-Fontan cardiac catheterization, and no fenestration.
Conclusions:In Asian population with a high incidence of heterotaxy syndrome, the heterotaxy syndrome was identified as the poor prognostic factors for Fontan surgery. The preoperative low mPAP and less AVVR are associated with better early and long-term outcomes of Fontan surgery.
